Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What PTSC must do.

What PTSC must do.

posted on Jan 10, 2008 05:36PM

Step 1.  Issue PDS participation pass through rights that entitle shareholders to 50% of the PDS cash dstributions.

 This protects 50% of the cash from a 35% corporate tax. 

Locks in the shares and protects current shareholders from future dilution.

The holdng company will retain rights to 50% of the PDS dsitribution.

 

In other words 25^ of PDS cash to PTSC and 25% straighht to shareholders. 

 This will also force PTSC into a positition where incubation is necessary for teh executive board to be cpmensated beyond salary.

 Simultaneous with the rights offering will be a 1:20 reverse split leaving only 20 million PTSC shares outstanding and a market price pre rights distribution of 

10 dollars per share.

One thr rights are distributed on a 1:1 basis with post -reverse split the 20 million rights will trade separately.  I believe the reduced number of shares

increased price , and clear distinction between PTSC and the PDS cash will help management focus, and bring in large investors  

 It is what must be done to protect shareholders from  continued dilution by employees stock options and warrants 

2
Jan 10, 2008 05:48PM
Fut
3
Jan 10, 2008 07:48PM
1
Jan 11, 2008 02:44AM
1
Jan 11, 2008 02:44AM
Share
New Message
Please login to post a reply